LabCorp's Acquisition of Sequenom Passes Antitrust Review | GenomeWeb

NEW YORK (GenomeWeb) – Laboratory Corporation of America said today that its pending acquisition of Sequenom has passed antitrust review.

Expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 satisfies one of the conditions needed to complete the acquisition.

In July, LabCorp said it planned to acquire Sequenom for $302 million in cash, or $2.40 per share, in a deal it expected to close by the end of the year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.